Leaflet STREPTASE 1500000UI lyophilisate for solution for injection / infusion

Product code:
W10030001
Quantity:
1
Indicated for:
thrombolysis; myocardial infarction; ischemic stroke
Route of administration:
injectable / infusion
Substance:
streptokinase (thrombolytic)
ATC
B01AD01 — Blood and blood forming organs | Antithrombotic agents | Antithrombotic agents | Enzymes
Streptokinase is a thrombolytic medication used to dissolve blood clots in cases of acute myocardial infarction, pulmonary embolism, or deep vein thrombosis. It works by activating plasminogen, which breaks down fibrin in clots.

The medication is administered intravenously under strict medical supervision, usually in intensive care units. It is important for patients to be monitored to prevent complications such as excessive bleeding.

Patients should be aware of potential side effects, such as allergic reactions, fever, or hypotension. It is important to inform the doctor of any unusual symptoms.

Common side effects include fever, hypotension, and allergic reactions. In rare cases, severe bleeding or anaphylactic reactions may occur. Patients should be informed of these risks before administration.

General data about STREPTASE 1500000UI

Substance:
streptokinase
Date of latest medicines list:
01-07-2013
Product code:
W10030001
Concentration:
1500000UI
Pharmaceutical form:
lyophilisate for solution for injection / infusion
Quantity:
1
Product type:
Original
Prescription status:
S — Medicines dispensed with a restricted medical prescription, reserved for use in certain specialized fields.

Concentrations available for streptokinase

  • 1500000UI
  • 250000UI
  • 750000ui